|
HS Code |
783754 |
As an accredited Boc-4-Bromo-D-Beta-Phenylalanine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive Boc-4-Bromo-D-Beta-Phenylalanine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
For chemists working in research and innovation, finding the right building block shapes the outcome of both simple and complex projects. Boc-4-Bromo-D-β-Phenylalanine stands out among synthetic amino acids not just because of its chemical structure, but the way it influences reliable peptide assembly. The model, C14H16BrNO4, puts it into the category of modified phenylalanine derivatives, marked by a tert-butoxycarbonyl (Boc) protected amine and a bromine atom at the 4-position on the aromatic ring. These subtle changes do more than tweak theory—they create chances for real improvements in yield, selectivity, and downstream modifications.
The fundamental qualities of phenylalanine, one of life’s basic amino acids, have made it a go-to building block in peptide chemistry. Swap in a bromine on the aromatic ring and you get something much more versatile. You can introduce cross-coupling options, or attach specialized functional groups through Suzuki, Heck, or other palladium-catalyzed conditions. Over the last decade, chemists have turned to these halogenated scaffolds as gateways for late-stage diversification. Modifying the backbone with a D-isomer, rather than the standard L-form, offers not just altered stereochemistry but real changes in biological behavior and resistance to enzymatic degradation. For people challenged by peptide stability or looking to boost medicinal potential, Boc-4-Bromo-D-β-Phenylalanine presents a practical advantage that goes beyond textbook curiosity.
Anyone synthesizing peptides on solid supports knows purification and protection can make or break a project. The Boc group, a well-established protecting group, guarantees stability across a range of pH zones and during storage. In practice, this stability cuts down on byproducts and simplifies chromatography. Boc-protected amino acids give researchers more breathing room, letting them focus on larger challenges. Once it’s time to remove the Boc group, mild acidic conditions are all it takes—no need for harsh chemicals that might damage more fragile parts of your molecule. Drawing on my own time in academic labs, cycles of peptide coupling and deprotection often stall when a less robust protecting group falls apart unexpectedly. Boc offers peace of mind and reproducibility batch after batch.
Boc-4-Bromo-D-β-Phenylalanine usually appears as a white to off-white crystalline solid. Its presence is felt at the bench in every small bottle or sealed vial, sitting among other amino acid derivatives. Stable under dry conditions, it resists clumping or degradation over months, letting researchers return to their unlabeled tubes with confidence. Molecular weight hovers around 342 grams per mole, which any experienced chemist will spot as a good size for handling and weighing without static or rapid loss into the lab environment. While not the cheapest modification in this class, the unique reactivity of the aryl bromide clearly offsets cost, especially in longer or high-value peptide sequences.
Boc-4-Bromo-D-β-Phenylalanine is not just an academic curiosity: its growing presence in drug discovery, peptidomimetic design, and specialty materials points to its practical appeal. Drug designers aiming for non-natural backbones often seek the D-configuration to improve peptide half-life or evade protease enzymes, which often chop up natural L-forms. With an activated aryl bromide, medicinal chemists have explored direct attachment of fluorophores, therapeutic handles, or even linkers for bioconjugation. In early-stage lead optimization projects, screening panels built on these frameworks have led to peptides with new activities—sometimes uncovering mechanisms inaccessible through traditional scaffolds.
On the materials science front, the presence of a halogen on the ring unlocks pathways to supramolecular assemblies or specialty polymers. For instance, assembling molecules that fluoresce, bind metals, or stack in organized arrays often depends upon key substituents in positions like the para-bromo of Boc-4-Bromo-D-β-Phenylalanine. As a result, researchers value it both in biomedical work and in forming new nanostructured materials where the right amino acid derivative can turn a marginal design into a solid result.
Stacking Boc-4-Bromo-D-β-Phenylalanine against plain Boc-D-Phenylalanine or even its chloro or iodo siblings highlights important differences. The unsubstituted phenylalanine lacks a leaving group, so it can’t undergo the same suite of Suzuki or Sonogashira couplings. While 4-chloro or 4-iodo versions can fill similar roles, the bromine strikes a balance: it activates the ring just enough for reliable cross-coupling but resists unplanned side reactions during assembly. It’s a matter of practicality, not just theory—the balance of reactivity and stability supports the widest range of peptide modifications without flooding the bench with problematic byproducts or unwanted isomers.
From my own experience, synthesizing peptides that later needed fluorescence tags or small-molecule drug conjugates, the flexibility afforded by bromine was indispensable. I recall parallel runs comparing 4-bromo, 4-chloro, and 4-iodo analogues under almost identical conditions. The 4-bromo derivative hit a sweet spot, allowing fast reactions, easy monitoring by TLC or LC/MS, and clean separations, in contrast to the overreactive iodo analogues and the sluggish chloro types. So, while chemistry textbooks might list several halogen choices, actual bench results put Boc-4-Bromo-D-β-Phenylalanine ahead for most real-world projects.
Laboratory safety always takes priority. Boc-4-Bromo-D-β-Phenylalanine does not release fumes or strong odors, making it less challenging when compared to many protected amino acids with reactive side chains. Provided researchers use basic gloves, eye protection, and lab coats, risks remain low during standard use. Like any organic solid, it should not be inhaled or ingested. Routine bench chemistry rules apply: mix only with compatible solvents, avoid strong bases during storage, and keep away from direct sunlight. Dry, sealed storage ensures a solid shelf life. In a crowded freezer or chemical pantry, this molecule rarely causes confusion or accidental mix-ups, thanks in part to its distinct structure and well-recorded melting point.
Once synthesized—whether purchased commercially or prepared in-house—Boc-4-Bromo-D-β-Phenylalanine is straightforward to analyze. Classic proton NMR displays the aromatic resonances in predictable spots, while the Boc tert-butyl peak pops up unmistakably. Thin-layer chromatography with a basic ethyl acetate/hexanes solvent system provides a fast read on purity. High-resolution mass spectrometry, now a staple in most labs, quickly confirms the exact mass including the bromine isotope pattern. Analytical HPLC shows strong separation from typical impurities, so peptide chemists can ensure their supply stays above 98% purity with little extra labor. In larger-scale work, regular purity checks and storage in small aliquots prevent slow breakdown and protect against repeated thaw-and-freeze damage.
Despite its flexibility, every protected amino acid presents learning curves. In solid-phase peptide synthesis, the electronic effects of the aryl bromide sometimes reduce coupling efficiency with standard activation agents like HBTU or DIC, especially in crowded or hindered sequences. Mixing up the proportions of base or slightly tweaking solvent systems can restore yields, but these small variables remind chemists of the real-world subtleties that separate a good synthesis from a failed run. In solution-phase work, too much heat during Boc removal leads to partial bromine loss or decomposition—best to proceed slowly, with close monitoring. Sharing lab experience: freshly making solutions rather than dipping into old stock, and adding a tiny excess of coupling agent, has often rescued a synthesis on a tight budget or deadline.
For applications involving further cross-coupling after peptide assembly, careful purification of the protected peptide step ensures that only the desired site is altered. Trace side reactions, though rarely catastrophic, can slip in during storage if water or acid vapor enters the bottle. People working in humid climates sometimes store these protected amino acids with a scoop of molecular sieves, just as a precaution. Well-labeled, tightly sealed containers always justify the ounce of prevention.
Pharmaceutical researchers, academic labs, and biotech companies each have their favorites among amino acid derivatives. Boc-4-Bromo-D-β-Phenylalanine keeps showing up on procurement lists because it solves practical problems: hard-to-modify peptide sequences, metabolic instability, or the need to introduce non-natural functions. A review from the last five years in leading chemistry journals shows an uptick in peptides for imaging, targeted therapeutics, and bespoke catalysts that relied on aryl bromides in the D-phenylalanine position. Reports from industrial contract research organizations echo this trend, where speed to result and reliability matter as much as creative chemistry.
In my own circle, working alongside veterans of both pharma and academic synthesis, the ability to shift from standard coupling protocols to late-stage diversification stands out. Time after time, projects stuck at the purification or coupling step get a fresh start with more robust, versatile building blocks. The bromine not only permits additional reactions but serves as a signpost on a molecule—clear to both analyst and synthetic chemist—which can speed up troubleshooting and collaboration between teams.
Peptide chemistry walks a line between simplicity and exploration. Having tools like Boc-4-Bromo-D-β-Phenylalanine lets research teams install various chemical groups after initial assembly, all without exposing fragile peptide bonds to harsh treatments. By preserving the D-configuration, molecules can slip past standard metabolic pathways or tweak selectivity at biological targets. Protein engineering teams now have more ways to mimic post-translational modifications, attach imaging labels, or optimize receptor interactions. None of these are purely theoretical. Published success stories and patent filings confirm concrete results with boronate esters, fluorescent dyes, and even radiolabels for PET imaging—always linking the original D-phenylalanine derivative to new horizons.
For those working at the intersection of chemistry and biology, options like this mean saying yes to more creative ideas. While unprotected or L-form analogues have their place, unique features of Boc-4-Bromo-D-β-Phenylalanine open exit ramps to designs that previously would have required an entire new synthetic pathway. Looking at a project’s timeline, this kind of flexibility can make the difference between completion this quarter and another round of disappointing delays.
A molecule’s worth often shows in its role bridging science and the clinic. In cancer targeting peptides or neuroimaging probes, the need to site-specifically install new functional groups is not just a luxury, it’s a requirement. The bromine substituent supports direct and reliable access to targeted radiolabeling—a hot topic as more clinicians seek peptide-based diagnostics with short half-lives and sharp localization. Collaborating with medicinal chemists, I’ve seen projects speed up by days or even weeks because the peptide chemist “baked in” a bromine tag that needed only a short cross-coupling step to finish. This stepwise building and modular design appeals to both process chemists and regulatory teams, who favor streamlined, well-tracked methods.
Looking at patent trends and clinical literature, many lead peptide drugs, from anti-infectives to metabolic modulators, now use non-standard amino acids to improve performance. Boc-4-Bromo-D-β-Phenylalanine often appears early in the discovery phase—found in combinatorial libraries, then carried through to clinical leads for its compatibility with standard synthesis and regulatory-friendly deprotection conditions. This continuity reassures both research teams and quality control inspectors, streamlining handover from benchtop success to process development.
The modern toolkit for peptide science now expects aryl halides as a matter of course. Once a peptide incorporates Boc-4-Bromo-D-β-Phenylalanine, direct modifications such as alkynylation, amination, or alkoxylation become possible. These are not mere curiosities—they support attachment of macrolide pharmacophores, delivery tags, or chemical “handles” enabling pull-down and labeling experiments. Competition for faster, cleaner peptide modifications has led to steady adoption of this derivative, especially in settings where rapid SAR (structure-activity relationship) exploration is in play.
From my background supporting collaborative workflows, one regular pain point comes from mismatched reactivity: a robust aryl bromide remains inert through repeated cycles of peptide assembly, but springs to life under standard palladium catalysis, making so-called “last mile” chemistry possible right before purification and analysis. Teams working across time zones or with staggered projects realize the value of this predictability. The chemistry behaves as literature predicts, limiting failed reactions and maximizing overlap with existing reagent libraries.
Seasoned chemists count on experience as much as protocol. Boc-4-Bromo-D-β-Phenylalanine consistently survives the rough-and-tumble storage conditions in busy research buildings. With a melting point typically reported between 88–94°C under dry nitrogen, the powder stays unchanged in standard laboratory freezers for over a year. Avoiding excess humidity and labeling vials with both date and batch number gave my group the confidence to draw from larger stock, only resorting to fresh synthesis if physical changes appeared. Slight yellowing signals breakdown, but in routine work, such degradation occurs rarely if material is kept cool and tightly closed.
Where problems crop up, they usually track to water ingress or accidental exposure to acids strong enough to start Boc cleavage. Quick attention to solid-state storage—desiccator boxes or vacuum tubes—solves these headaches. Most working chemists agree that major synthesis hiccups arise from poor solvent choice or forgetting to let the compound reach room temperature before opening a cold vial. Following basic chemistry hygiene keeps Boc-4-Bromo-D-β-Phenylalanine as reliable as more famous amino acid derivatives.
Each year brings new discoveries, many fueled by better chemical tools. Open conversations at conferences and in the pages of leading chemistry publications point to a rising tide of interest in late-stage peptide modifications and site-specific tagging. Boc-4-Bromo-D-β-Phenylalanine answers several pressing needs at once—allowing high-value functionalization, supporting chiral control, and surviving typical peptide assembly protocols. The product fits seamlessly into research pipelines, supporting larger collaborative projects between academia, pharma, and biotech. These strengths keep the demand steady, as researchers increasingly face targets resistant to standard peptide backbones and conservative chemistry approaches.
Personal anecdotes and published protocols both highlight the importance of robust, versatile amino acid derivatives. Boc-4-Bromo-D-β-Phenylalanine provides more than a reactive handle: it offers reliability and adaptability for both day-to-day laboratory synthesis and big-picture innovation. As more teams shift toward complex, multi-step peptide projects with critical deadlines, this molecule stands as a trustworthy partner, enabling strategies that balance creativity with solid, reproducible laboratory science.